Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN89716803) titled 'Role of rifaximin in acute pancreatitis' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Prevention
Primary Sponsor: Dayanand Medical College & Hospital
Condition:
Acute pancreatitis
Digestive System
Intervention:
Randomization:
Computer-generated randomization list. The randomization code was held by an independent pharmacist and was revealed only after database lock. Both the patients and treating team were blinded to treatment allocation. Allocation ratio: 1:1. Each patient was as...